Bate, Andrew

Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery

Norén, G. N., Hopstadius, J., & Bate, A. (2013) · Statistical Methods in Medical Research

Statistical Methods in EpidemiologyStatistical Methods in Clinical Trials

Cited by 336

Decision support methods for the detection of adverse events in post-marketing data

Hauben, M., & Bate, A. (2009) · Drug Discovery Today

Pharmacovigilance and Adverse Drug ReactionsData-Driven Disease Surveillance

Cited by 163

Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden

Bomze, D., Hasan Ali, O., Bate, A., & Flatz, L. (2019) · JAMA Oncology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 129

The need for guardrails with large language models in pharmacovigilance and other medical safety critical settings

Hakim, J. B., Painter, J. L., Ramcharran, D., Kara, V., Powell, G., Sobczak, P., Sato, C., Bate, A., & Beam, A. (2025) · Scientific Reports

Pharmacovigilance and Adverse Drug ReactionsArtificial Intelligence in Healthcare and Education

Cited by 32

Introduction to Drug Safety and Pharmacovigilance

Jose, J., Cox, A. R., & Bate, A. (2024) · Principles and Practice of Pharmacovigilance and Drug Safety

Pharmacovigilance and Adverse Drug ReactionsPatient Safety and Medication Errors

Cited by 3